Bariatric surgery and the COVID-19 pandemic: SICOB recommendations on how to perform surgery during the outbreak and when to resume the activities in phase 2 of lockdown.
Giuseppe NavarraIman KomaeiGiuseppe CurròLuigi AngrisaniRosario BelliniMaria Rosaria CerboneNicola Di LorenzoMaurizio De LucaMirto FolettoPaolo GentileschiMario MusellaMonica NannipieriLuigi PiazzaStefano OlmiVincenzo PiloneMarco RaffaelliGiuliano SarroAntonio VitielloMarco Antonio ZappaDiego FoschiPublished in: Updates in surgery (2020)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its related disease, coronavirus disease 2019 (COVID-19), has been rapidly spreading all over the world and is responsible for the current pandemic. The current pandemic has found the Italian national health system unprepared to provide an appropriate and prompt response, heavily affecting surgical activities. Based on the limited data available in the literature and personal experiences, the Società Italiana di Chirurgia dell'OBesità e Malattie Metaboliche (SICOB) provides recommendations regarding the triage of bariatric surgical procedures during the COVID-19 pandemic defining a dedicated path for surgery in morbidly obese patients with known or suspected COVID-19 who may require emergency operations. Finally, the current paper delineates a strategy to resume outpatient visits and elective bariatric surgery once the acute phase of the pandemic is over. Models developed during the COVID-19 crisis should be integrated into hospital practices for future use in similar scenarios. Surgeons are presented with a golden opportunity to embrace systemic change and to drive their professional future.
Keyphrases
- coronavirus disease
- respiratory syndrome coronavirus
- bariatric surgery
- sars cov
- weight loss
- obese patients
- minimally invasive
- roux en y gastric bypass
- healthcare
- emergency department
- coronary artery bypass
- public health
- gastric bypass
- current status
- quality improvement
- systematic review
- climate change
- adipose tissue
- primary care
- patients undergoing
- type diabetes
- percutaneous coronary intervention
- pulmonary embolism
- electronic health record
- coronary artery disease
- surgical site infection
- staphylococcus aureus
- machine learning
- pseudomonas aeruginosa
- biofilm formation
- escherichia coli
- adverse drug
- artificial intelligence